Pfizer, BioNTech Sign New Global Collaboration Agreement for First mRNA-based Shingles Vaccine
January 6th 2022This will be the third collaboration between Pfizer and BioNTech in the infectious diseases field, following the influenza vaccine collaboration in 2018 and the COVID-19 vaccine collaboration in 2020.
Read More